CONTEXT: Periodontitis is an inflammatory disease of tooth-supporting tissue leading to bone destruction and tooth loss. Periodontitis affects almost 50% of adults greater than 30 years of age. OBJECTIVE: This study evaluated the association between biomarkers linked to bone formation and resorption with the occurrence and progression of periodontal disease in older men (≥ 65 y). DESIGN: The Osteoporotic Fractures in Men (MrOS) study is a prospective, observational study among men 65 years of age and older. SETTING: This ancillary study, Oral and Skeletal Bone Loss in Older Men, was conducted at two of the six MrOS study sites (Birmingham, AL and Portland, OR). PATIENTS: Patients underwent medical and dental evaluation. Diagnoses of periodontitis were based on clinical attachment loss, pocket depth, calculus, plaque, and bleeding on a random half-mouth. Bone metabolism biomarkers included serum levels of calcium, phosphate (Pi), alkaline phosphatase, albumin, carboxy-terminal collagen crosslinks (CTX), N-terminal propeptides of type I procollagen, isoform 5b of tartrate-resistant acid phosphatase, and urine alpha- carboxy-terminal collagen crosslinks (alpha-CTX) and beta-CTX and serum levels of calciotropic hormones vitamin D (25(OH)D) and PTH. MAIN OUTCOME MEASURES: The aim of this study is to correlate bone metabolism biomarkers with prevalence and progression of periodontal disease in older men. RESULTS: Patients with more severe periodontitis had significantly higher levels of PTH (P trend = .0004), whereas 25(OH)D was lower (P trend = .001). In a subset of men reevaluated at a second dental visit, improvement of periodontitis was associated with lower alpha-CTX, beta-CTX, and CTX levels at baseline after adjusting for age, site, and body mass index. CONCLUSION: This study suggests that a distinct set of biomarkers of bone metabolism are associated with more severe periodontal disease (PTH, 25(OH)D) and periodontal progression (alpha-CTX, beta-CTX, and CTX) over time.
CONTEXT: Periodontitis is an inflammatory disease of tooth-supporting tissue leading to bone destruction and tooth loss. Periodontitis affects almost 50% of adults greater than 30 years of age. OBJECTIVE: This study evaluated the association between biomarkers linked to bone formation and resorption with the occurrence and progression of periodontal disease in older men (≥ 65 y). DESIGN: The Osteoporotic Fractures in Men (MrOS) study is a prospective, observational study among men 65 years of age and older. SETTING: This ancillary study, Oral and Skeletal Bone Loss in Older Men, was conducted at two of the six MrOS study sites (Birmingham, AL and Portland, OR). PATIENTS: Patients underwent medical and dental evaluation. Diagnoses of periodontitis were based on clinical attachment loss, pocket depth, calculus, plaque, and bleeding on a random half-mouth. Bone metabolism biomarkers included serum levels of calcium, phosphate (Pi), alkaline phosphatase, albumin, carboxy-terminal collagen crosslinks (CTX), N-terminal propeptides of type I procollagen, isoform 5b of tartrate-resistant acid phosphatase, and urine alpha- carboxy-terminal collagen crosslinks (alpha-CTX) and beta-CTX and serum levels of calciotropic hormones vitamin D (25(OH)D) and PTH. MAIN OUTCOME MEASURES: The aim of this study is to correlate bone metabolism biomarkers with prevalence and progression of periodontal disease in older men. RESULTS:Patients with more severe periodontitis had significantly higher levels of PTH (P trend = .0004), whereas 25(OH)D was lower (P trend = .001). In a subset of men reevaluated at a second dental visit, improvement of periodontitis was associated with lower alpha-CTX, beta-CTX, and CTX levels at baseline after adjusting for age, site, and body mass index. CONCLUSION: This study suggests that a distinct set of biomarkers of bone metabolism are associated with more severe periodontal disease (PTH, 25(OH)D) and periodontal progression (alpha-CTX, beta-CTX, and CTX) over time.
Authors: Michael J LaMonte; Kathleen M Hovey; Robert J Genco; Amy E Millen; Maurizio Trevisan; Jean Wactawski-Wende Journal: J Periodontol Date: 2012-07-19 Impact factor: 6.993
Authors: Peggy M Cawthon; Neeta Parimi; Elizabeth Barrett-Connor; Gail A Laughlin; Kristine E Ensrud; Andrew R Hoffman; James M Shikany; Jane A Cauley; Nancy E Lane; Douglas C Bauer; Eric S Orwoll; Steven R Cummings Journal: J Clin Endocrinol Metab Date: 2010-07-14 Impact factor: 5.958
Authors: Eric Orwoll; Carrie M Nielson; Lynn M Marshall; Lori Lambert; Kathleen F Holton; Andrew R Hoffman; Elizabeth Barrett-Connor; James M Shikany; Tien Dam; Jane A Cauley Journal: J Clin Endocrinol Metab Date: 2009-01-27 Impact factor: 5.958
Authors: Douglas C Bauer; Patrick Garnero; Stephanie L Harrison; Jane A Cauley; Richard Eastell; Kris E Ensrud; Eric Orwoll Journal: J Bone Miner Res Date: 2009-12 Impact factor: 6.741
Authors: Afaf Zia; S Hakim; A U Khan; A Bey; H Ateeq; S Parveen; S Khalid; Fnk Yusufi Journal: J Bone Miner Metab Date: 2022-01-24 Impact factor: 2.626
Authors: Ulrike Schulze-Späte; Iman Mizani; Kristina Rodriguez Salaverry; Jaime Chang; Christina Wu; Meaghan Jones; Peter J Kennel; Danielle L Brunjes; Tse-Hwei Choo; Tomoko S Kato; Donna Mancini; John Grbic; P Christian Schulze Journal: ESC Heart Fail Date: 2017-03-01
Authors: Mohammed Nasser Alhajj; Esam Halboub; Abdullah G Amran; Abdulaziz A Alkheraif; Fuad A Al-Sanabani; Bandar M Al-Makramani; Abdulghani A Al-Basmi; Fawaz A Al-Ghabri Journal: BMC Oral Health Date: 2019-05-28 Impact factor: 2.757